Pinealon
Quick facts
- Researched for
- Memory, brain aging, brain health, possible Alzheimer’s-related applications, healthy aging and longevity
- Route or form
- Injection
- Evidence so far
- Both findings are mixed reports from people, on memory and healthy aging.
- Not established
- No large, well-run trial shows it helps thinking or Alzheimer’s disease, or slows aging.
- Where to get it
- At our partner, US Precision Peptides.Go to Next step
By the Learn Peptides editorial team · Updated · How We Research
What people are researching it for
People are researching Pinealon for memory, brain aging, brain health, possible Alzheimer’s-related applications, healthy aging, and longevity.
Reasons people look into Pinealon. An interest is not a promise that it works.
- Cognitive & mood
- Longevity & energy
Reports are mixed: some note small memory changes, others little effect or worse sleep.
Community reports
Community reports are mixed. Some people describe subtle changes in memory or mental clarity, while others notice little effect or more interrupted sleep. Interest also centers on brain aging and longevity.
Pinealon is a three-amino-acid peptide studied mainly for neuroprotection and aging-related brain biology. Cell and animal work is more developed than the human evidence. A handful of human reports exist, but they are small and methodologically limited, so Pinealon remains an early research compound rather than an established cognitive or longevity therapy.
What this is based on
- Community reportsWhat people describe noticing. Not proof of cause.
- Learn Peptides explanationOur own plain-English summary of the sources. It is not a source itself.
There are a few human reports, plus lab and animal studies on the aging brain.
Pinealon, also called EDR, has a small number of human reports plus cell and animal research on brain protection and aging.
No large, well-run trial shows it helps thinking or Alzheimer’s disease, or slows aging.
No modern large, well-controlled trial has shown clear cognitive benefit, benefit in Alzheimer’s disease, or slower human aging.
Safety notes
Based on what people report. Useful for spotting patterns, but not controlled evidence.
Human safety, pharmacokinetics and long-term outcomes remain inadequately characterized.
One small 2015 study also reported prooxidant activity and a decrease in CD34+ hematopoietic progenitor markers.
It is a short peptide of 3 amino acids, also known as EDR.
Pinealon is commonly identified in the published literature as the short tripeptide Glu-Asp-Arg, abbreviated EDR. It is an injectable US Precision Peptides product.
Next step
US Precision Peptides
About product links
Purchases at US Precision Peptides help keep Learn Peptides free.